Exclusive interview with Pharma Microbiology Boston Conference Chair Lynne Ensor, speaks about Coronavirus Read more
Exclusive Interview with Martin Everett, CSO, Antabio, ahead of the Superbugs & Superdrugs Conference Read more
Harbour BioMed Announces Completion of Phase 1 Study in China of HBM9161, an Anti-FcRn Antibody Read more
FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer Read more
FORMA Therapeutics Announces FT-4202 Granted Fast Track Designation And Rare Pediatric Disease Designation For Treatment Of Sickle Cell Disease Read more